Gerardo Gatti

Co-Founder & Head of Clinical Research at OncoPrecision

Gerardo has a degree in Biochemistry and a PhD in Immunology from the College of Chemical Science of the National University of Córdoba. His postdoctoral training took place at the Fundación para el Progreso de la Medicina (FPM), a high-complexity diagnostics lab in Córdoba, Argentina. Gerardo conducted field work at Dr. Mandruzzato’s laboratory at the Department of Oncological and Surgical Sciences, at the University of Padova, Italy and Dr. Coussens’ laboratory at the Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University in Portland.

He has extensive research experience in the fields of immunology and immuno-oncology. In 2013, he led a team of researchers that conducted clinical evaluations of new biomarkers in solid tumors, one of the objectives of the Translational exploration consortium in clinical oncology (FPM, CONICET and Clinic Hospital consortium). In 2014, Gerardo took a position as researcher at FPM where he leads his own immunology cancer research team. His group has conducted important research on new prognosis biomarkers discovery and therapeutic targets in breast cancer.


Org chart


Teams


Offices

This person is not in any offices


OncoPrecision

12 followers

OncoPrecision is a platform therapeutics company integrating high-throughput patient-derived biology with AI/ML to develop ADCs and bispecific antibodies with a high probability of success, focused on addressing unmet needs in oncology.


Employees

11-50

Links